REGEMAT 3D Launches the World’s Only GelMA-Graphene Hydrogel for AdvancedTissue Engineering

Granada, Spain – February 19, 2025 – REGEMAT 3D is proud to unveil the world’s only
GelMA–Graphene hydrogel, a revolutionary electroconductive bioink developed for
next-generation tissue engineering applications.
This unique biomaterial, co-developed by REGEMAT 3D, Graphenano, and Tessenderlo
Group, and validated by University of Granada, University of Barcelona, and University
of Alcalá, represents a breakthrough in the convergence of biofabrication and functional
tissue generation.
The GelMA–Graphene hydrogel stands out for its:
▪ Biocompatibility
▪ Optimized physical and mechanical properties
▪ Suitability for nerve, muscle, cardiac, liver, cartilage, and bone tissue engineering
These attributes position the material as a powerful tool for researchers and clinicians
working on the interface between cell biology, biomaterials, and regenerative medicine.

Discover the full scientific foundation in the publication:
“Development and characterization of graphene derivative–GelMA hybrid bioinks for the
generation of bioartificial tissue substitutes via 3D bioprinting” – ACC Science Journal
Read here

For further details, upcoming launch information, or collaboration inquiries, contact us at
info@regemat3d.com or reach out on LinkedIn.